Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/58474
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cardona Attard, Carol | - |
dc.contributor.author | Fava, Stephen | - |
dc.date.accessioned | 2020-07-01T11:03:57Z | - |
dc.date.available | 2020-07-01T11:03:57Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Cardona Attard, C., & Fava, S. (2019). Benefits and risks of testosterone therapy in older men. Minerva Urologica e Nefrologica= The Italian Journal of Urology and Nephrology, 71(3), 217-229. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/58474 | - |
dc.description.abstract | Adult-onset hypogonadism is used to define androgen deficiency and its associated symptoms commonly occurring in middle-aged and elderly men, who are unable to mount an adequate compensatory gonadotropin response but may also have an element of testicular failure. It often occurs in relation with chronic metabolic conditions such as diabetes and the metabolic syndrome. There is a growing demand from elderly men for testosterone therapy. The physician should therefore be well-informed so as the patient can make an informed decision. Indeed, testosterone therapy in older men has been a matter of debate, especially with regard to its impact on cardiovascular events and mortality. Not all studies have reported consistent results regarding its effect on diabetes, obesity and the metabolic syndrome. In contrast, it appears to improve sexual, physical function and bone density and it does not appear to increase the risk of prostate cancer; however, it increases hematocrit and hemoglobin levels. Therefore, testosterone therapy might provide significant beneficial effects in older symptomatic hypogonadal men; treatment should be individualized, and comorbidities addressed. Further research is required into its long-term effects. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | Edizioni Minerva Medica | en_GB |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_GB |
dc.subject | Hypogonadism | en_GB |
dc.subject | Hormone therapy | en_GB |
dc.subject | Testosterone -- Therapeutic use | en_GB |
dc.subject | Testosterone -- Physiological effect | en_GB |
dc.subject | Cardiovascular abnormalities | en_GB |
dc.title | Benefits and risks of testosterone therapy in older men | en_GB |
dc.type | article | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | peer-reviewed | en_GB |
dc.identifier.doi | 10.23736/S0393-2249.19.03301-0 | - |
dc.publication.title | Minerva Urologica e Nefrologica | en_GB |
Appears in Collections: | Scholarly Works - FacM&SMed |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Benefits_and_risks_of_testosterone_therapy_in_older_men_2019.pdf Restricted Access | 697.83 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.